Pu-Erh Tea

Add Content

• Definition
• Introduction
• Signs & Symptoms
• Research Summary

Presentation Slides

---

Executive Summary

---

Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Pu-Erh Tea" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.

Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Pu-Erh Tea" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.

Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Pu-Erh Tea" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.

A Experimental Study published in 2023 in the journal Food & Function found that Pu-erh tea can potentially prevent depression-like behaviors induced by nighttime blue light from electronic devices by reshaping gut microbiota and increasing short-chain fatty acids generation. The methodology used involved administering water or Pu-erh tea to two groups of mice for 120 days, followed by a 45-day exposure to a blue light simulating electronic equipment during the night. The effect of the tea and blue light on the mice's behavior and gut microbiota was then studied. Results indicated that the blue light induced depression-like behaviors and upset the gut microbiota in mice that were previously healthy. In the discussion of results, it was noted that the intake of Pu-erh tea significantly reshaped the mice's gut microbiota, especially the metabolism of short-chain fatty acids, which helped protect the integrity of the intestinal barrier. This improvement not only lessened damage to the blood-brain barrier, but also reduced neuroinflammation by inhibiting certain cellular pathways. This ultimately regulated neurotransmitters like brain-derived neurotrophic factor and serotonin, demonstrating the potential of Pu-erh tea to prevent blue light induced depression-like behaviors by impacting the gut-brain axis.

A Animal Study published in 2022 in the journal Food Research International found that Pu-erh tea and its ingredient theabrownin improve liver, jejunum, and adipose tissue functions in metabolic syndrome mice, modulating circadian rhythm, glycerophospholipid, and linoleic acid metabolism. In this study, varied technological applications such as metagenomics, transcriptomics, and metabolomics were utilized to explore the anti-metabolic syndrome mechanism of Pu-erh tea and theabrownin in mice with metabolic syndrome. These scientific technologies allowed the researchers to understand and explore improvements in the physiological functions of liver, jejunum, and adipose tissues in the metabolic syndrome mice as a result of Pu-erh tea and theabrownin interventions. The investigation also focused on changes to the hepatic transcriptome, revealing that both of these interventions had the capacity to regulate the circadian rhythm pathway. The results showcased that both interventions succeeded in the modulation of glycerophospholipid and linoleic acid metabolism, this was established through a comprehensive analysis of serum and brain metabolome. Further analysis of faecal metagenome demonstrated an increase in the relative abundance of certain bacterium and a decrease in others due to both interventions. However, in comparison to Pu-erh tea, theabrownin exhibited a more pronounced influence as regards upregulating hepatic antioxidants and downregulating hepatic inflammatory factors, although there was only a slight reduction in obesity-linked short-chain fatty acids in faeces of the metabolic syndrome mice. Overall, the experiment provided essential insights into the various ways these two elements function and provide treatment for metabolic syndrome.

A Experimental Study published in 2022 in the journal Food Chemistry found that Pu-erh tea, through the increase of Cinnabarinic acid, can improve obesity induced by circadian rhythm disorders by enhancing fat metabolism and altering gut microbes. In this study, a CRD-induced obesity model in mice was developed and Pu-erh tea was used as an intervention. The effect of Pu-erh tea on obesity was observed and determined to come from its production of Cinnabarinic acid (CA). CA was found to promote adipose tissue lipolysis and heat generation response, increasing the sensitivity of fat cells to hormones and neurotransmitters. This was accomplished by targeting the expression of specific receptor proteins in adipose tissue. These processes improved mitochondrial activity in the fat cells and expedited metabolic processes in the adipose tissue, thereby speeding up glucose and fat metabolism. In the final stage of the study, CA was found to make changes in the gut microbiota and short-chain fatty acids which further helped to improve the lipid accumulation mediated by CRD. The researchers concluded that the increase in CA, caused by drinking Pu-erh tea and reaching the fat tissue through blood circulation, could be a crucial mechanism to reduce obesity induced by circadian rhythm disorders.

A Animal Study published in 2022 in the journal Foods found that Pu-erh tea has been validated to have significant anti-oxidative effects, reducing serum MDA levels and increasing serum SOD and GSH-Px levels. The methodology used in this study involved a systematic literature review and meta-analysis to explore the anti-oxidative effects of pu-erh tea. Seven databases were meticulously searched up to the date of 21 February 2020, using the specific keywords 'pu-erh' in combination with 'superoxide dismutase', 'glutathione peroxidase', or 'malondialdehyde'. The results from the meta-analysis demonstrated significant effects of pu-erh tea on anti-oxidation. It was found to reduce serum MDA levels whilst simultaneously increasing serum SOD and GSH-Px levels. Through the systematic review and meta-analyses, it was validated that various ingredients in pu-erh tea extracts do indeed have the anti-oxidation effects that have long been part of conventional wisdom, but until now had limited supporting evidence.

A Experimental Study published in 2022 in the journal Journal of Agricultural and Food Chemistry found that Pu-erh tea may prevent circadian rhythm disorders by promoting tryptophan metabolism and signaling interactions in the gut-liver-brain axis. Healthy mice were administered water or 0.25% Pu-erh tea over a period of seven weeks, and then subjected to a disruption of their light/dark cycle for forty days. The assessment of effects was based on changes in neurotransmitter secretion and gene oscillations, intestinal inflammation, and the balance of intestinal microbes and metabolites. Results indicated that Pu-erh tea had beneficial impacts in regulating neurotransmitter secretion and clock gene oscillations, especially indole and 5-hydroxytryptamine pathways, a key process involving the gut-liver-brain axis. Moreover, the tea's metabolites improved release of brain hormones, thus enhancing hepatic glycolipid metabolism and lowering intestinal oxidative stress. Further observed beneficial effects included promotion of liver lipid metabolism and reduction of intestinal inflammation, via the enterohepatic circulation.

A Review Article published in 2022 in the journal Journal of Traditional Chinese Medical Sciences found that Pu-erh tea possesses therapeutic mechanisms potentially beneficial for metabolic diseases due to its interaction with liver and gut microbiome. The methodology of this research involved reviewing and summarising the processing elements and bioactive components of pu-erh tea. Extensive study of relative human and animal trials was conducted, and the potential therapeutic mechanisms of this tea were examined and extrapolated. In discussing the results, it was discovered that pu-erh tea evidently has beneficial effects on metabolic diseases, such as hypocholesterolemic and hypolipidemic effects. The research points to the conclusion that the tea's interaction with the liver and gut microbiome is the major contributing factor to these health benefits. It helps regulate tea biotransformation and endogenous metabolism, underlining the tea's potential use in therapeutic interventions.

A Experimental Study published in 2021 in the journal Frontiers in Nutrition found that Co-fermentation of Ganpu tea with Chachi peel alters its chemical profile, reducing certain compounds while increasing others, thus enhancing its unique flavor. In the research, the effects of Chachi peel cofermentation on the chemical profile of Ganpu tea were examined using an ultra-high-performance liquid chromatography-Q Exactive Orbitrap mass spectrometry (UHPLC-QE Orbitrap MS)-based qualitative and quantitative method combined with multivariate analysis. A total of 171 compounds were identified using a three-level strategy, including seven phenolic acids, 11 flavan-3-ols, and 27 flavonoids and flavonoid glycosides identified in pu-erh tea for the first time. The principal component analysis (PCA) of untargeted metabolomics and orthogonal partial least squares discriminant analysis (OPLS-DA) models of targeted components revealed significant differences in the chemical profiles between raw pu-erh tea and Ganpu tea. The cofermentation process significantly reduced the total contents of phenolic acids, flavan-3-ols, and flavonoid aglycone. However, most of the quercetin glycosides, myricetin glycosides, and vitexin increased significantly. Additionally, hesperidin, a flavonoid glycoside only found in Chachi, was detected in pu-erh tea for the first time after cofermentation. Hence, this process clearly impacts the chemical composition and content changes in pu-erh tea, suggesting that cofermentation accelerates the fermentation of pu-erh tea and improves its unique taste.

A Review Article published in 2021 in the journal Food Chemistry found that Pu-erh tea, with its complex components, interacts greatly with gut microbiomes and holds significant potential for healthcare applications. Pu-erh tea undergoes a post-fermentation process involving various microorganisms, leading to highly complex components. This tea has its potential benefit due to its rich interactions with the gut microbiomes; the structure and the homeostasis of which are deeply connected to human wellness and progress of various diseases. This study provides a systemic review of the current findings pertaining to the bioactive components of Pu-erh tea and their interactions with gut microbiomes. For the discussion of results, the beneficial effects of Pu-erh tea on gut microbiomes may establish its role in healthcare. These benefits are due to the tea's bioactive components' impacts on the structure of the gut microbiomes, and subsequent health improvements. Additionally, the establishment of "components-function-indicators" clues can propel the standardisation of the tea's fermentation process and development of functional tea-related products.

A Systematic Review published in 2021 in the journal Chinese Medicine found that A variety of Chinese herbal medicines have been reported to effectively prevent or treat nonalcoholic fatty liver disease by regulation of the gut microbiota and the gut-liver axis. The key roles of CHMs in the regulation of gut microbiota and the gut-liver axis along with their mechanisms (such as modulating intestinal permeability, reducing the inflammatory response, protecting liver cells, improving lipid metabolism, and modulating nuclear receptors), were well summarized. All the knowledge and information presented here will be very helpful for researchers to better understand the applications and mechanisms of CHMs for treatment of NAFLD.

A Review Article published in 2021 in the journal Gastroenterology Insights found that Tea polyphenols can help rebalance gut microbiota, alleviating imbalances caused by obesity, diabetes, and UV damage, with effects varying by tea type. The methodology of this review involved the process of collecting and analyzing various studies dealing with the effects of tea polyphenols on gut microbiota in both humans and animals. This included studies observing the overall gut health in relation to conditions such as obesity, diabetes, and UV damage. The comparative approach was used to differentiate the effects of different types of tea on distinct bacterial taxa present in the gut. In discussing the results, it was found that tea polyphenols consistently improved and diversified gut microbiota in animal tests. In contrast, while human trials also showed improved gut health seemingly due to a prebiotic-like effect of tea polyphenols, the evidence was not as conclusive. However, the outcomes did show that different types of teas had differing effects on the bacterial taxa present in the gut.

A Network Pharmacology published in 2020 in the journal Nutrients found that Ganpu tea, derived from Pu-erh tea and the pericarp of Chachi, enhances antioxidant capacities and modulates gut microbiota beneficially more than Pu-erh tea alone. A thorough chemical analysis was conducted on hot-water extracts of Ganpu tea using ultra-high performance liquid chromatography and quadrupole-time-of-flight tandem mass spectrometry, which identified a total of 92 constituents. Considering the antioxidant properties of Ganpu tea, an experiment was designed and carried out where rats were fed with Ganpu tea over a long period. The same experiment was done using Pu-erh tea and the pericarp of Chachi separately, allowing for comparisons of antioxidant capacities between them and Ganpu tea. The results showed that Ganpu tea had a substantial impact on improving the activities of superoxide dismutase and glutathione peroxidase, both essential antioxidants, more than Pu-erh tea. This indicated a superior antioxidant capacity of Ganpu tea. Further, it significantly increased the abundance of specific gut bacteria, offering a suggestion of the potential benefits of Ganpu tea in human gut microbiota modulation. The results underscore the health benefits of Ganpu tea in enhancing antioxidant activities and promoting beneficial gut microbiota.

A Experimental Study published in 2019 in the journal Frontiers in Pharmacology found that Pu-erh tea's ability to lower blood pressure is primarily due to theabrownins and caffeine, which cause vasodilation irrespective of the endothelium. For the research methodology, researchers used pu-erh tea aqueous extract to analyze its effects on rat thoracic aortas previously tightened by Phenylephrine or KCl. They observed the isometric tension and intracellular calcium to gauge the direct effects of the tea. The aqueous tea extract was separated into different fractions using organic solvents to identify the specific active components. They assessed the impact these had on the arteries. The results demonstrated that the vessels relaxed in response to the pu-erh tea extract, irrespective of whether the endothelium was removed or preincubated with potassium channel blockers. Furthermore, the contractibility of the vessels induced by Phenylephrine or CaCl under different conditions was reduced. There was also a decrease in the KCl-induced increase of intracellular calcium in rat aortic smooth muscle cells. Among the different components, researchers found that the chloroform precipitate of the pu-erh tea extract resulted in the strongest vasodilation. Theabrownins, a major part of this precipitate, and caffeine were identified as the active components causing vasodilation in an endothelium-independent manner.

A Experimental Study published in 2019 in the journal Nature Communications found that Pu-erh tea was found to lower triglyceride and total cholesterol levels more significantly than green, oolong, or black teas. Comparative studies using rodents treated with Pu-erh tea, green tea, and black tea provided supporting evidence that fully fermented Pu-erh tea is more effective in causing hypolipidemic and hypocholesterolemic effects compared to other partially fermented and non-fermented teas.

A Systematic Review published in 2019 in the journal Nutrition & Diabetes found that Pu-erh tea has considerable inhibitory effects on alpha-amylase and alpha-glucosidase, indicating potential anti-hyperglycemic benefits. The study employed a systematic review method to investigate the inhibitory effects of Pu-erh tea on alpha-amylase and alpha-glucosidase. English and Chinese databases, specifically PubMed, EBSCO, SCOPUS, Cochrane Library, Web of Science, Airti Library, CNKI Library, and Google Scholar, were thoroughly searched up to March 22, 2018 for eligible studies. Search terms included Pu-erh, Pu'er, alpha-amylase, and alpha-glucosidase, aiming to collect an integrative body of literature demonstrating the link between Pu-erh tea and its presumed anti-hyperglycemic effects. Concerning the discussion of the results, the systematic review incorporated six studies that had examined inhibitory effects on alpha-glucosidase and seven that had investigated alpha-amylase. The analysis revealed that Pu-erh tea does indeed demonstrate inhibitory effects on both alpha-amylase and alpha-glucosidase. However, high heterogeneity was identified across the various studies, which could be attributed to the complex changes in chemical composition resulting from varying extents of fermentation. The significant findings suggest the tea's potential as a natural remedy for hyperglycemia.

A Network Pharmacology published in 2019 in the journal Molecules found that Raw pu-erh tea extract has superior antioxidant capacity due to higher polyphenol content, but ripe pu-erh offers a cheaper, yet effective alternative for antioxidant or antimicrobial properties. The investigation first utilised mass spectrometry and UV spectroscopy to profile and quantify the primary components of two types of fermented Chinese green tea - raw and ripe pu-erh. This took place after a procedure known as chromatographic separation, used to separate the components of the extract. Beyond this, the activities of the extracts, relating to antioxidant potential, antimicrobial capability and enzyme inhibition, were established and linked to their main components. In discussing the results, though having similar caffeine content and equivalent enzyme inhibition and antimicrobial activities, raw pu-erh extract demonstrated a stronger antioxidant ability owing to it containing a higher concentration of polyphenols. However, the benefits of raw pu-erh tea do not provide enough justification for its higher production costs in comparison to the ripe variety. The ripe variety of pu-erh tea was shown to be a cost-effective alternative for creating products with antioxidant or antimicrobial characteristics.

A Animal Study published in 2019 in the journal RSC Advances found that Ripened Pu-erh tea extract demonstrates a stronger anti-diabetic impact than raw Pu-erh tea extract, potentially due to the fermentation process and its probiotic benefits to certain gut bacteria. The methods of the study involved the processing and analysis of Pu-erh tea leaves, specifically the raw variety and the ripened type which goes through pile-fermentation. To identify differences in the anti-diabetic effects of both types, the researchers subjected their extracts to ultra-high-performance liquid chromatography paired with quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF/MS) and UHPLC coupled with photodiode array (PDA) analyses. These techniques helped in identifying new compounds formed and those that increased due to the fermentation. The research also performed a study observing the effects of Ripened Pu-erh Tea on beneficial gut bacteria, namely Lactobacillus, Bifidobacterium, Akkermansia, and Roseburia. In their discussion, the researchers noted that the ripened Pu-erh tea extract exhibited more potent anti-diabetic effects on two key indicators of diabetes: two-hour postprandial blood glucose and fasting blood glucose. This superiority over the raw Pu-erh tea extract was attributed to 17 newly formed components and those that increase after fermentation such as quinic acid, gallic acid, caffeine, and puerin I. Furthermore, ripened Pu-erh tea showed to have a probiotic role on certain beneficial gut bacteria, implying an extra potential avenue for its anti-diabetic effects.

A Animal Study published in 2019 in the journal International Journal of Food Science & Technology found that Pu-erh tea has a significant anti-hyperglycaemic effect, with its efficacy increasing over time and with higher dosages. The research team systematically searched five English databases and three Chinese ones up to July 31, 2018 for studies related to the term 'Pu-erh' and the concepts of 'blood sugar', 'blood glucose', and 'hyperglycaemia'. The team used the software RevMan 5 and Stata to carry out a meta-analysis, which ultimately included two studies on mice, with sixteen records total. The results from the meta-analysis reveal that Pu-erh tea has a strong anti-hyperglycaemic effect on mice. More noteworthy were the observations that, over longer periods of intervention, the tea can reduce fasting blood glucose levels. Additionally, a higher dose of Pu-erh tea was found to lower fasting blood glucose significantly more, suggesting dosage is crucial for achieving the best outcome.

A Experimental Study published in 2017 in the journal Food & Function found that When combined, Silibinin and Pu-erh tea extract prove more effective in preventing non-alcoholic fatty liver disease than when used individually. The research used obese mice (ob/ob) and fed them a high-fat diet along with the oral administration of Silibinin, Pu-erh tea extract, or both, over a six-week period. Concurrently, lean mice were used as a control group, consuming a regular diet. The blood chemical index and histopathological evaluations were analyzed to determine the effects of Silibinin and Pu-erh tea extract on the mice, particularly in terms of weight, blood lipid levels, fat metabolism, and inflammatory response. The results showcased that in comparison to the group of mice suffering from non-alcoholic fatty liver disease, the groups which received either Pu-erh tea extract, Silibinin, or a combination of both exhibited significant reductions in weight and blood lipid levels. Furthermore, both Silibinin and Pu-erh tea extract, whether used alone or in tandem, were found to improve fat metabolism and decrease the inflammatory response to a certain extent. The combined group, however, displayed the strongest efficacy in adjusting fat metabolism and inhibiting oxidative stress. They also revealed the drugs' ability to inhibit fat synthesis and improve cholesterol homeostasis by regulating the expression of specific genes. The combined effect was superior to that of individual usage.

A Experimental Study published in 2016 in the journal Food Science and Human Wellness found that Pu-erh tea water extracts could potentially enhance liver health and reduce oxidative stress in rats on a high-fat diet. In this study, fifty SD rats were split into five distinct groups and subjected to a high-fat diet. Their body weights were noted daily. Researches measured the serum levels of malondialdehyde (MDA), glucose, catalysts such as alanine aminotransferase and aspartate aminotransferase, nitric oxide synthase, and pyruvate kinase. Besides, hepatic glycogen levels were assessed, along with the activity of liver enzymes like total superoxide dismutase, catalase, and glutathione peroxidase. These measurements were consistently undertaken for a duration of 12 weeks. The findings showcased a decrease in the body weight and fat index of rats after the administration of Pu-erh tea extract. The reduction in body weight and fat index was accompanied by a decrease in malondialdehyde and nitric oxide synthase levels. Interestingly, there was also a noticeable increase in the activities of hepatic total superoxide dismutase, catalase, and glutathione peroxidase. These findings suggest that the Pu-erh extract might reduce the oxidant stress state, inhabit lipid peroxidation, and protect liver health in rats. Simultaneously, the extracts seemed to boost the production of liver glycogen, enhance the activity of pyruvate kinase, and decrease glucose levels, thereby possibly safeguarding the liver from diseases linked to Type II Diabetes.

A Experimental Study published in 2016 in the journal PLOS One found that Pu-erh tea's fermentation process alters its microbial community, with aging significantly impacting raw but not ripened Pu-erh, and toxic metabolites present support brewing customs. The researchers looked into the microbial communities inherent in Pu-erh tea, a special blend originating from Yunnan, China. The fresh leaves of the tea plant, Camellia sinensis, undergo two types of fermentation- the traditional raw fermentation and the faster, ripened variant. Using high-throughput rDNA-amplicon sequencing, a method to identify and quantify various bacteria and fungi present, they examined both the leaves and both types of Pu-erh tea. The study also explored possible mycotoxins in the tea profiles through quantitative liquid chromatography-tandem mass spectrometry, a technique used to detect and quantify various substances. Despite observing significant alterations in the fungal and bacterial compositions due to both fermentation processes, the researchers found the aging process to produce noteworthy changes in raw Pu-erh but not in the ripened type. They identified 390 fungal operational taxonomic units (OTUs) and 629 bacterial OTUs in the leaves and teas. Interestingly, despite the difference in the speed and nature of the fermentation processes, ripened and well-aged raw Pu-erh teas exhibited similar microbial communities alien from those observed in young, raw Ph-erh tea. They also found 25 toxic metabolites, primarily of fungal origin, with the most common being patulin and asperglaucide. These facts lend credibility to the Chinese custom of discarding the first preparation of the Pu-erh tea and using the damp tea for subsequent brewing.

A Randomised Controlled Trial published in 2016 in the journal Clinical Interventions in Aging found that Daily consumption of Puer tea extract results in significant weight loss, reduced body fat, and improved lipid profile in a non-Asian overweight population. This study employed a randomized, double-blind, placebo-controlled design to evaluate the effects of Puer tea extract. A selection of 59 overweight or mildly obese subjects with high cholesterol levels were chosen and assigned to either consume Puer tea extract or a placebo daily for 20 weeks. Measurements were taken at the beginning and every 4 weeks to analyse lipids, C-reactive protein, and fasting blood glucose. Body composition changes were also observed using a dual-energy X-ray absorptiometry scan. Appetite and energy levels were also self-reported by the participants at each visit. The results indicated a significant weight loss tied to Puer tea extract consumption compared to the placebo. Reductions in fat were noted across several body areas and overall fat mass. These findings were significant within the Puer tea extract group but not when compared to the placebo. The consumption of the tea was further associated with an improved lipid profile, including a significantly reduced cholesterol ratio after 4 weeks and a sustainably normal level of other lipoproteins. The tea consumption was also related to a temporary reduction in appetite but showed no notable changes in fasting glucose or C-reactive protein levels compared to the placebo.

A Experimental Study published in 2014 in the journal Molecular Medicine Reports found that Consumption of Pu-erh tea can effectively alleviate symptoms of constipation, with effects comparable to the medicinal drug bisacodyl. The methodology in the research focused on observing the effects of Pu-erh tea on induced constipation in mice. The study induced constipation through activated carbon and then assessed various factors, such as changes in body weight, dietary intake, gastrointestinal transit times, and physical characteristics of feces. The impact of Pu-erh tea was compared to that of bisacodyl, a well-known laxative. Specific dosage levels of Pu-erh tea were utilized while continuously observing the physiological responses and changes in mice. The results showed a marked improvement in all major parameters related to constipation in mice treated with Pu-erh tea. It was found that body weight, dietary intake and water consumption were better in the tea-treated groups than in the carbon-induced constipation group. The gastrointestinal transit times were also considerably improved, with Pu-erh tea equivalent in efficiency to bisacodyl. In addition to this symptomatic relief, the serum levels of substances associated with gastrointestinal motility and function were significantly affected, indicating that Pu-erh tea has potential anti-constipation effects at a physiological level.

Moderation Tools

---

Topic